scientific program • symposia - American Society for Reproductive ...

P-10 ONE-YEAR OF FOLLOW-UP OF LEVONORGESTREL-
RELEASING INTRAUTERINE SYSTEM USE IN PATIENTS
WITH HEMOSTATIC DISORDERS WITH AND WITHOUT
ANTICOAGULANT THERAPY.
C. S. Vieira 1 , M. B. Brito 1 , L. C. O. de Oliveira 2 , M. C. Pintao 2 , R. A.
Ferriani 1 . 1 Department of Gynecology and Obstetrics, Ribeirão
Preto School of Medicine, University of São Paulo, Ribeirao Preto,
Sao Paulo, Brazil; 2 Hemostasis Unit - Internal Medicine Department,
Ribeirão Preto School of Medicine, University of São Paulo, Ribeirao
Preto, Sao Paulo, Brazil.
P-11 UNSCHEDULED BLEEDING IN CONTINUOUS ORAL
CONTRACEPTIVE PILL A COMPARISON OF PROGESTIN DOSE.
B. Kaneshiro 1 , A. Edelman, N. Carlson 3 , J. Jensen 2 . 1 Department
of Obstetrics and Gynecology, University of Hawaii, Honolulu, HI;
2 Department of Obstetrics and Gynecology, Oregon Health &
Science University, Portland, OR; 3 Department of Biostatistics and
Informatics, University of Colorado Denver, Aurora, CO.
P-12 CONTRACEPTIVE COUNSELING AND PRACTICES IN
WOMEN WITH CANCER.
B-S. L. Maslow, C. Gracia. Obstetrics and Gynecology, Hospital of
the University of Pennsylvania, Philadelphia, PA.
P-13 ANALYSIS OF ADVERSE EVENTS ASSOCIATED WITH
ESSURE HYSTEROSCOPIC STERILIZATION REPORTED TO THE
MAUDE DATABASE, 2002-2011.
Z. A. Al-Safi, V. I. Shavell, D. T. Hobson, J. M. Berman, M. P. Diamond.
Obstetrics and Gynecology, Wayne State University/Detroit Medical
Center, Detroit, MI..
P-14 CONTRACEPTIVE USE PATTERNS: REVERSIBLE,
PERMANENT, LONG AND SHORT ACTING METHODS OF
CONTRACEPTION.
K. L. Schulman 1 , H. J. Cabral 2 , A. Prezioso 3 , J. Pocoski 3 , L. A. Costa 1 ,
A. W. Law 3 . 1 Outcomes Research Solutions, Inc., Bolton, MA;
2 Department of Biostatistics, Boston University School of Public
Health, Quincy, MA; 3 Health Economics and Outcomes Research,
Bayer Healthcare Pharmaceuticals, Wayne, NJ.
P-15 PERCEPTIONS AND SELF- REPORTED ELIGIBILITY FOR
INTRAUTERINE DEVICES IN AN INNER-CITY POSTPARTUM
PATIENT POPULATION.
L. Londra, Y. Franco, R. Roberts, G. Vilchez, T. Tipton, M. Diamond.
OBGYN, Wayne State University/Detroit Medical Center, Detroit, MI.
__________________________________________________________
FEMALE REPRODUCTIVE ENDOCRINOLOGY
P-16 EFFECT OF RESVERATROL ON PROLIFERATION AND
STEROIDOGENESIS OF RAT OVARIAN THECA-INTERSTITIAL
CELLS.
I. Ortega1,2 , D. H. Wong1 , A. B. Cress1 , A. Sokalska1,3 , S. D. Stanley4 , A.
J. Duleba1 . 1Department of Obstetrics and Gynecology, University of
California, Davis, Davis, CA; 2IVI Madrid, Madrid, Spain; 3Department of Gynecology, Obstetrics and Gynecological Oncology,
Karol Marcinkowski, Poznan, Poland; 4Department of Molecular
Biosciences, University of California, Davis, Davis, CA.
P-17 LETROZOLE INCREASES GROWTH OF RAT THECA-
INTERSTITIAL CELLS AND CYP17A1 GENE EXPRESSION IN THE
RAT OVARY.
I. Ortega 1,2 , E. Stener-Victorin 3 , J. A. Villanueva 1 , A. Sokalska 1,4 , S. D.
Stanley 5 , A. J. Duleba 1 . 1 Department of Obstetrics and Gynecology,
University of California, Davis, Davis, CA; 2 IVI Madrid, Madrid, Spain;
3 Department of Physiology/Endocrinology, Institute of Neuroscience
and Physiology, Gothenburg, Sweden; 4 Department of Gynecology,
Obstetrics and Gynecological Oncology, Karol Marcinkowski
University of Medical Sciences, Poznan, Poland; 5 Department of
Molecular Biosciences, University of California, Davis, Davis, CA.
POSTER PRESENTATIONS
139
P-18 EFFECTS OF RESVERATROL ON RAT OVARIAN
GRANULOSA CELLS.
I. Ortega1,2 , D. H. Wong1 , A. B. Cress1 , J. A. Villanueva1 , S. D. Stanley3 ,
A. J. Duleba1 . 1Department of Obstetrics and Gynecology,
University of California, Davis, Davis, CA; 2IVI Madrid, Madrid, Spain;
3Department of Molecular Sciences, University of California, Davis,
Davis, CA.
P-19 TESTOSTERONE INHIBITS SUBCUTANEOUS ABDOMINAL
ADIPOGENESIS DURING ADIPOSE STEM CELL DIFFERENTIATION
TO PREADIPOCYTES.
G. Chazenbalk 1 , D. Irge 1,2 , A. Shah 1 , D. A. Dumesic 1 . 1 Department of
Obstetrics and Gynecology, David Geffen School of Medicine at
UCLA, Los Angeles, CA; 2 Department of Obstetrics and Gynecology,
Sackler School of Medicine, Tel Aviv University, Tel Aviv, Israel.
P-20 ATTRIBUTES NOT KNOWN TO CAUSE INFERTILITY: A
LEADING PERCEIVED ETIOLOGY OF INFERTILITY OF AFRICAN-
AMERICAN PARTICIPANTS IN THE STUDY OF WOMEN’S HEALTH
ACROSS THE NATION (SWAN).
A. E. Karmon 2 , S. Hailpern 2 , G. Neal-Perry 2 , R. Green 2 , N. Santoro 1 ,
A. J. Polotsky 1 . 1 Obstetrics and Gynecology, University of Colorado,
Aurora, CO; 2 Obstetrics and Gynecology, Albert Einstein College of
Medicine, Bronx, NY.
P-21 HOW LONG DOES IT TAKE THE AVERAGE COUPLE TO
GET PREGNANT? A SYSTEMATIC REVIEW OF WHAT WE KNOW.
B. Leader 1,2 , V. Baker 2,3 , D. Seifer 4 . 1 ReproSource, Inc, Woburn, MA;
C. D. Lynch. Department of Obstetrics and Gynecology, The Ohio
State University College of Medicine, Columbus, OH.
P-22 THE INFLUENCE OF BODY MASS INDEX (BMI) ON
PREGNANCY OUTCOMES AMONG JAPANESE INFERTILE
WOMEN.
M. Funabiki, S. Taguchi, T. Hayashi, Y. Tada, K. Kitaya, Y. Nakamura.
Oak Clinic, Osaka, Japan.
P-23 SOCIAL AND CULTURAL DETERMINANTS OF DELAYED
PRESENTATION FOR INFERTILITY CARE AMONGST ASIAN
COMPARED TO CAUCASIAN WOMEN IN THE UNITED STATES.
T. L. A. Spitzer1 , E. B. Johnstone2 , H. G. Huddleston1 . 1Reproductive Sciences, University of California San Francisco, San Francisco, CA;
2Department of Obstetrics and Gynecology, University of Utah, Salt
Lake City, UT.
P-24 REVERSAL OF IDIOPATHIC HYPOGONADOTROPIC
HYPOGONADISM IN A FEMALE WITH ANOSMIA.
E. H. Goldstein 1 , R. H. Reindollar 1 , M. B. Goldman 1 , L. Layman 2 .
1 Obstetrics and Gynecology, Dartmouth Hitchcock Medical Center,
Lebanon, NH; 1 Obstetrics and Gynecology, Medical College of
Georgia, Augusta, GA.
P-25 IN SUBCLINICAL HYPOTHYROIDISM, THYROXINE
(T4) REQUIREMENT MAY INCREASE IN EARLY PREGNANCY
RESULTING FROM GONADOTROPIN STIMULATION.
K. R. Hammond 1 , N. A. Cataldo 2 , J. A. Hubbard 1 , M. P. Steinkampf 1 .
1 Alabama Fertility Specialists, Birmingham, AL; 2 Birmingham, AL.
P-26 TREATMENT OF OVULATORY WOMEN WITH
UNEXPLAINED INFERTILITY WITH CLOMIPHENE CITRATE
AND INTRAUTERINE INSEMINATION: DOES DOSAGE AFFECT
CLINICAL PREGNANCY RATE?
N. M. Barker 1 , S. Rahim 1 , M. Johnson 2 , S. Weil 1 , J. Liu 1 , W. Hurd 1 .
1 Obstetrics & Gynecology, University Hospitals Case Medical Center,
Cleveland, OH; 2 Reproductive Biology, Case Western Reserve
University, Cleveland, OH.
P-27 LUTEINIZING HORMONE POLYMORPHISMS CANNOT
EXPLICATE ENDOMETRIOSIS ASSOCIATED INFERTILITY.
C. Schmitz, E. de Conto, U. Matte, V. K. Genro, C. A. Souza, J. S.
Cunha-Filho. Serviço de Ginecologia e Obstetrícia, Hospital de
Clínicas de Porto Alegre, Porto Alegre, Rio Grande do Sul, Brazil.